Senate won’t confirm, say, Matt Gaetz as attorney general? Just wait until they leave — maybe even if they don’t want to.

SOUTH SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PLRX), today announced that Keith Cummings, M.D., Chief ...

BEACON-IPF Phase 2b trial on track for full enrollment in the first quarter of 2025 with data anticipated in mid-2026 SOUTH ...

Wireless intercom provider Pliant Technologies said it has expanded its sales network, adding manufacturer’s representative ...

Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage clinical biotechnology company and leader in the discovery and development of novel therapeutics for the ...

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are covering the firm, Marketbeat Ratings reports. Eight ...

Joseph Stringer’s rating is based on several positive developments at Pliant Therapeutics. The company has provided a clear timeline for its key programs, notably the completion of enrollment for the ...

Analyst Edward Nash of Canaccord Genuity maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report), retaining the price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Your selective amnesia about your own privilege is a disservice to those truly striving against adversity. Your dissonance ...

Royal scions across the country have condemned Congress leader Rahul Gandhi for calling their ancestors pliant Maharajas who ...